Suppr超能文献

吸烟会增加克罗恩病肠外表现的风险。

Smoking increases the risk of extraintestinal manifestations in Crohn's disease.

作者信息

Ott Claudia, Takses Angela, Obermeier Florian, Schnoy Elisabeth, Müller Martina

机构信息

Claudia Ott, Angela Takses, Florian Obermeier, Elisabeth Schnoy, Martina Müller, Department of Internal Medicine I, University of Regensburg, 93042 Regensburg, Germany.

出版信息

World J Gastroenterol. 2014 Sep 14;20(34):12269-76. doi: 10.3748/wjg.v20.i34.12269.

Abstract

AIM

To demonstrate a high prevalence of extraintestinal manifestations (EIMs) in a prospective population-based cohort of inflammatory bowel disease (IBD) patients at first diagnosis as well as during the early course of the disease.

METHODS

EIMs are common in patients with IBD. Data on the frequency of EIMs have mostly been assessed in patients from tertiary centers; however, data about the prevalence of EIMs at first diagnosis as well as factors influencing their incidence during the early course of disease from prospective population-based cohorts are scarce. We present data of patients of our population-based "Oberpfalz cohort" (Bavaria, Germany) from first diagnosis (up to 3 mo after first diagnosis) as well as during the early course of the disease. Possible risk factors were assessed by calculating the relative risk (RR) as well as using logistic regression analysis.

RESULTS

In total, data of 257 newly diagnosed patients with IBD were evaluated [161 Crohn's disease (CD), 96 ulcerative colitis (UC)]. Median duration of follow-up was 50 mo after first diagnosis. In 63.4% of all patients (n = 163), an EIM was diagnosed at any point during the observation period. At first diagnosis, patients with CD had a significantly increased risk of an EIM [n = 69 (42.9%)] compared with UC patients [n = 21 (21.9%); P < 0.001; RR = 1.96; 95%CI: 1.30-2.98]. Active smoking increased the risk of CD patients developing an EIM during the early course of the disease, but notably not of UC patients (P = 0.046; RR = 1.96; 95%CI: 1.01-3.79). In addition, using logistic regression analysis, the need for IBD-related surgery and a young age at first diagnosis were identified as risk factors for the development of an EIM in CD patients. No association with EIMs was found for the factors sex, localization of the disease and positive family history of IBD. In contrast, no key factors which increased the risk of development of an EIM could be identified in UC patients.

CONCLUSION

We found a high prevalence of EIM in this cohort at first diagnosis and during the early course of the disease. In patients with CD, smoking, need for surgery and younger age at first diagnosis were risk factors for the development of an EIM.

摘要

目的

在一个基于人群的前瞻性炎症性肠病(IBD)患者队列中,证明肠外表现(EIMs)在首次诊断时以及疾病早期阶段的高患病率。

方法

EIMs在IBD患者中很常见。EIMs发生频率的数据大多是在三级中心的患者中评估的;然而,关于首次诊断时EIMs的患病率以及来自前瞻性人群队列中疾病早期阶段影响其发生率的因素的数据却很少。我们展示了我们基于人群的“上普法尔茨队列”(德国巴伐利亚)患者从首次诊断(首次诊断后3个月内)到疾病早期阶段的数据。通过计算相对风险(RR)以及使用逻辑回归分析来评估可能的风险因素。

结果

总共评估了257例新诊断的IBD患者的数据[161例克罗恩病(CD),96例溃疡性结肠炎(UC)]。首次诊断后的中位随访时间为50个月。在所有患者的63.4%(n = 163)中,在观察期的任何时间点都诊断出有EIM。在首次诊断时,CD患者发生EIM的风险显著高于UC患者[n = 69(42.9%)]与[n = 21(21.9%)];P < 0.001;RR = 1.96;95%CI:1.30 - 2.98]。主动吸烟增加了CD患者在疾病早期阶段发生EIM的风险,但UC患者中未观察到明显增加(P = 0.046;RR = 1.96;95%CI:1.01 - 3.79)。此外,通过逻辑回归分析,IBD相关手术的需求以及首次诊断时年龄较小被确定为CD患者发生EIM的风险因素。未发现性别、疾病部位和IBD家族史阳性与EIMs有关。相比之下,在UC患者中未发现增加EIM发生风险的关键因素。

结论

我们发现在该队列中首次诊断时以及疾病早期阶段EIM的患病率很高。在CD患者中,吸烟、手术需求和首次诊断时年龄较小是发生EIM的风险因素。

相似文献

1
Smoking increases the risk of extraintestinal manifestations in Crohn's disease.
World J Gastroenterol. 2014 Sep 14;20(34):12269-76. doi: 10.3748/wjg.v20.i34.12269.
2
Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort.
Scand J Gastroenterol. 2015 Mar;50(3):300-5. doi: 10.3109/00365521.2014.991752. Epub 2014 Dec 23.
3
[Incidence and risk factors of extraintestinal manifestations in children with inflammatory bowel disease].
Zhonghua Er Ke Za Zhi. 2019 Sep 2;57(9):694-699. doi: 10.3760/cma.j.issn.0578-1310.2019.09.009.
4
The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients.
United European Gastroenterol J. 2021 Sep;9(7):773-780. doi: 10.1002/ueg2.12125. Epub 2021 Aug 25.
7
Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: Frequency and relation with disease phenotype.
Indian J Gastroenterol. 2015 Jan;34(1):43-50. doi: 10.1007/s12664-015-0538-7. Epub 2015 Feb 7.
9
Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients.
World J Gastroenterol. 2014 Dec 14;20(46):17463-7. doi: 10.3748/wjg.v20.i46.17463.
10
Extraintestinal manifestations of inflammatory bowel disease and the influence of smoking.
Digestion. 2014;90(2):122-9. doi: 10.1159/000363228. Epub 2014 Oct 1.

引用本文的文献

2
Factors affecting the development of complications in Crohn's disease in patients undergoing intestinal resection.
Medicine (Baltimore). 2023 Feb 22;102(8):e32957. doi: 10.1097/MD.0000000000032957.
4
Pediatric Patient With Ulcerative Colitis-Associated Bronchiectasis.
ACG Case Rep J. 2020 Apr 7;7(4):e00365. doi: 10.14309/crj.0000000000000365. eCollection 2020 Apr.
5
Pyoderma Gangrenosum in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Dig Dis Sci. 2020 Sep;65(9):2675-2685. doi: 10.1007/s10620-019-05999-4. Epub 2020 Jan 10.
8
Risk factors for postoperative recurrence of Crohn's disease with emphasis on surgical predictors.
Ann Gastroenterol. 2017;30(6):598-612. doi: 10.20524/aog.2017.0195. Epub 2017 Sep 26.
9
Pulmonary dysfunction in 114 patients with inflammatory bowel disease.
Medicine (Baltimore). 2017 May;96(18):e6808. doi: 10.1097/MD.0000000000006808.
10
Care of inflammatory bowel disease patients in remission.
Gastroenterol Rep (Oxf). 2016 Nov;4(4):261-271. doi: 10.1093/gastro/gow032. Epub 2016 Oct 10.

本文引用的文献

1
Extraintestinal manifestations and complications in IBD.
Nat Rev Gastroenterol Hepatol. 2013 Oct;10(10):585-95. doi: 10.1038/nrgastro.2013.117. Epub 2013 Jul 9.
3
Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome?
World J Gastroenterol. 2011 Jun 14;17(22):2702-7. doi: 10.3748/wjg.v17.i22.2702.
4
Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn's disease: results from CARE.
Inflamm Bowel Dis. 2012 Jan;18(1):1-9. doi: 10.1002/ibd.21663. Epub 2011 Feb 23.
5
Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort.
Am J Gastroenterol. 2011 Jan;106(1):110-9. doi: 10.1038/ajg.2010.343. Epub 2010 Aug 31.
7
Inflammatory bowel disease in African American children compared with other racial/ethnic groups in a multicenter registry.
Clin Gastroenterol Hepatol. 2008 Dec;6(12):1361-9. doi: 10.1016/j.cgh.2008.07.032. Epub 2008 Oct 9.
8
How prevalent are extraintestinal manifestations at the initial diagnosis of IBD?
Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S198-9. doi: 10.1002/ibd.20597.
10
The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.
Eur J Gastroenterol Hepatol. 2008 Sep;20(9):917-23. doi: 10.1097/MEG.0b013e3282f97b33.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验